Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service

MITRE to Establish New AI Experimentation and Prototyping Capability for U.S. Government Agencies


MITRE is building a new capability intended to give its artificial intelligence (AI) researchers and developers access to a massive increase in computing power. The new capability, MITRE Federal AI Sandbox, will provide better experimentation of next generation AI-enabled applications for the federal government. The Federal AI Sandbox is expected to be operational by year's end and will be powered by an NVIDIA DGX SuperPODtm that enables accelerated infrastructure scale and performance for AI enterprise work and machine learning.

As U.S. government agencies seek to apply AI across their operations, few have adequate access to supercomputers and the deep expertise required to operate the technology and test potential applications on secure infrastructure.

"The recent executive order on AI encourages federal agencies to reduce barriers for AI adoptions, but agencies often lack the computing environment necessary for experimentation and prototyping," says Charles Clancy, MITRE, senior vice president and chief technology officer. "Our new Federal AI Sandbox will help level the playing field, making the high-quality compute power needed to train and test custom AI solutions available to any agency."

MITRE will apply the Federal AI Sandbox to its work for federal agencies in areas including national security, healthcare, transportation, and climate. Agencies can gain access to the benefits of the Federal AI Sandbox through existing contracts with any of the six federally funded research and development centers MITRE operates.

Sandbox capabilities offer computing power to train cutting edge AI applications for government use including large language models (LLMs) and other generative AI tools. It can also be used to train multimodal perception systems that can understand and process information from multiple types of data at once such as images, audio, text, radar, and environmental or medical sensors, and reinforcement learning decision aids that learn by trial and error to help humans make better decisions.

"MITRE's purchase of a DGX SuperPOD to assist the federal government in its development of AI initiatives will turbocharge the U.S. federal government's efforts to leverage the power of AI," says Anthony Robbins, vice president of public sector, NVIDIA. "AI has enormous potential to improve government services for citizens and solve big challenges, like transportation and cyber security."

The NVIDIA DGX SuperPOD powering the sandbox is capable of an exaFLOP of performance to train and deploy custom LLMs and other AI solutions at scale.

About MITRE

MITRE's mission-driven teams are dedicated to solving problems for a safer world. Through our public-private partnerships and federally funded R&D centers, we work across government and in partnership with industry to tackle challenges to the safety, stability, and well-being of our nation.


These press releases may also interest you

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: